166 related articles for article (PubMed ID: 23203646)
1. Treating vasculitis with conventional immunosuppressive agents.
Jayne D
Cleve Clin J Med; 2012 Nov; 79 Suppl 3():S46-9. PubMed ID: 23203646
[TBL] [Abstract][Full Text] [Related]
2. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
Hoffman GS
Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
[No Abstract] [Full Text] [Related]
3. Seven clinical conundrums in the treatment of ANCA-associated vasculitis.
Alba MA; Flores-Suárez LF
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S74-83. PubMed ID: 23663685
[TBL] [Abstract][Full Text] [Related]
4. [Uptodate in the management and treatment of ANCA-associated vasculitis].
Belaconi IN; Toma CL; Bogdan MA
Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and management of small vessel vasculitides].
Pettersson T; Karjalainen A
Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
[TBL] [Abstract][Full Text] [Related]
6. Use of methotrexate in ANCA-associated vasculitides.
Reinhold-Keller E; de Groot K
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S178-82. PubMed ID: 21044456
[TBL] [Abstract][Full Text] [Related]
7. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis.
Rich EN; Brown KK
Curr Opin Pulm Med; 2012 Sep; 18(5):447-54. PubMed ID: 22854508
[TBL] [Abstract][Full Text] [Related]
8. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.
Zand L; Specks U; Sethi S; Fervenza FC
Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467
[TBL] [Abstract][Full Text] [Related]
9. Management of ANCA associated vasculitis.
Wallace ZS; Miloslavsky EM
BMJ; 2020 Mar; 368():m421. PubMed ID: 32188597
[TBL] [Abstract][Full Text] [Related]
10. L44. Management of relapses in vasculitis.
Mouthon L
Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
[No Abstract] [Full Text] [Related]
11. The evolving treatment of ANCA-associated vasculitides.
Sauranen J; Salmela A; Kahlos K; Antonen J; Ekstrand A; Pettersson T
Duodecim; 2016; 132(16):1449-55. PubMed ID: 29188932
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of anti-neutrophil cytoplasmic antibody related vasculitis].
Galesić K; Horvatić I
Lijec Vjesn; 2014; 136(7-8):232-7. PubMed ID: 25327014
[TBL] [Abstract][Full Text] [Related]
13. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Tuin J; Sanders JS; van Beek AP; Hoek A; Stegeman CA
Arthritis Rheumatol; 2016 Apr; 68(4):986-92. PubMed ID: 27023359
[TBL] [Abstract][Full Text] [Related]
15. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR;
Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882
[TBL] [Abstract][Full Text] [Related]
16. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
17. Post-influenza vaccination vasculitides: a possible new entity.
Zafrir Y; Agmon-Levin N; Shoenfeld Y
J Clin Rheumatol; 2009 Sep; 15(6):269-70. PubMed ID: 19734729
[No Abstract] [Full Text] [Related]
18. Immunosuppressive and glucocorticoid therapy for the treatment of ANCA-asssociated vasculitis.
Neumann I
Rheumatology (Oxford); 2020 May; 59(Suppl 3):iii60-iii67. PubMed ID: 32348519
[TBL] [Abstract][Full Text] [Related]
19. L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's).
Monach PA
Presse Med; 2013 Apr; 42(4 Pt 2):575-6. PubMed ID: 23453209
[No Abstract] [Full Text] [Related]
20. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Tervaert JW; Stegeman CA; Kallenberg CG
Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):211-7. PubMed ID: 11224696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]